Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Jun 10.
Published in final edited form as: Crit Rev Biomed Eng. 2011;39(5):461–472. doi: 10.1615/critrevbiomedeng.v39.i5.60

Mathematical and Computational Models of Oxidative and Nitrosative Stress

Mahendra Kavdia 1
PMCID: PMC4051224  NIHMSID: NIHMS448635  PMID: 22196163

Abstract

The importance of nitric oxide (NO), superoxide (O2), and peroxynitrite (ONOO) interactions in physiologic functions and pathophysiological conditions such as cardiovascular disease, hypertension, and diabetes have been established extensively in in vivo and in vitro studies. Despite intense investigation of NO, O2, and ONOO biochemical interactions, fundamental questions regarding the role of these molecules remain unanswered. Mathematical models based on fundamental principles of mass balance and reaction kinetics have provided significant results in the case of NO. However, the models that include interaction of NO, O2, and ONOO have been few because of the complexity of these interactions. Not only do these mathematical and computational models provided quantitative knowledge of distributions and concentrations of NO, O2, and ONOO under normal physiologic and pathophysiologic conditions, they also can help to answer specific hypotheses. The focus of this review article is on the models that involve more than one of the 3 molecules (NO, O2, and ONOO). Specifically, kinetic models of O2 dismutase and tyrosine nitration and biotransport models in the microcirculation are reviewed. In addition, integrated experimental and computational models of dynamics of NO/O2/ONOO in diverse systems are reviewed.

Keywords: Nitric oxide, superoxide, peroxynitrite, hydrogen peroxide, superoxide dismutase, tyrosine nitration, endothelial cell, microcirculation, biotransport

I. INTRODUCTION

Nitric oxide (NO), reactive oxygen species (ROS), and reactive nitrogen species (RNS) are involved in numerous physiologic functions. NO, ROS, and RNS play a key role in signal transduction pathways, gene transcription, protein synthesis, and cell function. The interactions of NO, ROS, and RNS with biological systems lead to diverse outcomes that can be good or bad. An increasing body of evidence shows that ROS and RNS are important in the pathogenesis of many diseases including cardiovascular and neuronal diseases. Table 1 lists the literature reviews of NO, ROS, and RNS roles in various biological systems in the last decade. ROS and RNS are derived from partial reduction of oxygen and from NO, respectively. Both ROS and RNS can be in free radical and non–free radical forms. From a physiologic and pathophysiologic perspective, important ROS are superoxide anion (O2), hydroxyl radical (OH), hydrogen peroxide (H2O2), and hypochlorus acid (HOCl), whereas important RNS are peroxynitrite (ONOO), nitrogen dioxide (NO2), and nitrous anhydride (N2O3).

TABLE 1.

Recent Literature Reviews of Nitric Oxide, Reactive Oxygen Species, and Reactive Nitrogen Species’ Roles in Biological Systems

Review Topic Reference
General health and disease Pacher et al. (15)
Immune response Wink et al. (86)
Molecular mechanism and therapeutic implications in heart failure Nediani et al. (87)
Cytoneurotoxicity and neurologic disorders Metodiewa and Koska (88)
Regulation of endothelial barrier function Boueiz and Hassoun (89)
Intracellular signaling in skeletal muscle Powers et al. (90)
Regulation of neutrophil function Fialkow et al. (91)
Depolymerization of polysaccharides and its outcome Duan and Kasper (92)

II. NITRIC OXIDE, REACTIVE OXYGEN SPECIES, AND REACTIVE NITROGEN SPECIES

II.A. Nitric Oxide

NO, which is the endothelium-derived relaxing factor (EDRF), is a key signaling messenger in the cardiovascular systems for the regulation of blood pressure and vascular tone.1-3 The discovery of NO as EDRF led to the awarding of the 1998 Nobel Prize in physiology or medicine to investigators F. Murad, R.F. Furchgott, and L.J. Ignarro. In addition, NO plays many important functions in cardiovascular systems including maintenance of vascular integrity4 and inhibition of platelet aggregation, 5 leukocyte–endothelium adhesion,6 and vascular smooth muscle proliferation.7 A reduction in endothelial NO results in endothelial dysfunction, and abnormalities in NO signaling have been linked to many diseases including atherosclerosis, hypertension, hypercholesterolemia, diabetes mellitus, thrombosis, and stroke.8-16

NO is produced from the enzymatic oxidation of L-arginine to L-citrulline by several isoforms of NO synthase (NOS) enzymes,17 including neuronal NOS (nNOS), endothelial NOS (eNOS) and inducible NOS (iNOS). Recently, another NOS has been identified as mitochondrial NOS (mtNOS). These isoforms are divided based on their control of activity from intracellular calcium/calmodulin. The activity of nNOS and eNOS is dependent on a transient increase in intracellular calcium concentration, whereas the activity of iNOS is dependent at the level of transcription. NOS enzymes require several cofactors including tetrahydrobiopterin (BH4), flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN), nicotinamide adenine dinucleotide phosphate (NAD(P)H), and molecular oxygen for their enzymatic activities.

From NOS isoforms, eNOS is the principal source of bioavailable NO in vasculature. NO produced by endothelial cells diffuses to vascular smooth muscle cells, where it activates soluble guanylate cyclase (sGC) that catalyzes the conversion of guanosine triphosphate (GTP) to cyclic guanosine monophosphate (cGMP), thus relaxing smooth muscle cells and causing vasodilatation. The majority of endothelial NO diffuses into the vascular lumen, where NO rapidly reacts with hemoglobin in red blood cells (RBCs) in flowing blood. The role of RBCs in NO metabolism has been a focus of many experimental investigations and several NO modeling papers (reviewed by Tsoukias18). Using an integrated approach of computational modeling and experiments, Deonikar and Kavdia19-21 have recently reported that (1) the effective reaction rate for NO and RBC interaction is 0.2 × 105 · M-1 · s-1,19 (2) the RBC membrane permeability membrane between 0.0415 and 0.4 cm/s is required to maintain sufficient NO concentrations at the smooth muscle cell layer,20 and (3) the downstream transport of NO is possible under the right circumstances.21NO-sensitive dye DAF-2 (4,5 diaminofluorescein) and DAF-FM and selective inhibitors of NOS has enabled understanding of NO-producing sites in living tissues.22-24 A role of nNOS-generated NO in vascular function has been demonstrated.25,26 The nNOS containing nerve fibers, nerve terminals, and mast cells have been reported as a source of vascular NO.23 Non-neuronal cell types, including cardiac and skeletal myocytes, also have been shown to express nNOS. mtNOS, which is located in the inner mitochondrial membrane, modulates mitochondrial respiration and mitochondrial transmembrane potential. However, the contribution of mtNOS to tissue NO is controversial.27 NO production related to iNOS can be up to 1000-fold higher than that of eNOS or nNOS. Macrophages, leukocytes, and fibroblasts express iNOS as a defense mechanism; however, prolonged activity leads to asthma, inflammation, and arthritis.

II.B. Reactive Oxygen Species

Under normal physiologic conditions, a small fraction of the inspired oxygen (O2) used to generate energy by oxidative phosphorylation in mitochondria is converted to ROS. All cells of vascular tissue, including endothelial cells and smooth muscle cells, have enzyme systems that produce ROS. Primary ROS generated in the vascular tissue is O2 or H2O2. Important ROS production sources include NAD(P)H oxidases, mitochondria, eNOS, and xanthine oxidase. Out of these sources of O2 production, the membrane-associated NAD(P)H oxidase is a major source of O2 in vascular diseases, including cardiovascular disease.28,29 Enzyme superoxide dismutase (SOD) catalyzes the conversion of O2 to H2O2. H2O2 is converted to water by the enzymes catalase or glutathione peroxidase, which uses glutathione (GSH) as the reducing agent. O2 is highly reactive and has a very short half-life, whereas H2O2 is relatively stable and has a longer half-life.

In normal physiologic conditions, antioxidant systems protect against damage from ROS. These antioxidant systems include (1) antioxidants such as vitamins A, C, and E, and (2) enzyme systems such as SOD, glutathione peroxidase, and catalase. However, when ROS generation overwhelms the antioxidant defense, these radicals can alter cellular function by interacting with DNA, RNA, and fatty acids and can lead to apoptosis. This state is normally described as oxidative stress.30 Both O2 and H2O2 can alter intracellular signaling pathways, including regulation of migration and host defense through oxidation. O2 can react with NO; thus, O2 and H2O2 levels can be controlled by NO, and oxidative damages are limited to specific cellular sites of ROS generation. However, O2 reaction with NO forms peroxynitrite (RNS), which destroys BH431 required for the NO synthesis. The depletion of BH4 not only reduces NO synthesis but also results in uncoupling of eNOS that can lead to O2- production by eNOS.32

II.C. Reactive Nitrogen Species

NO reacts rapidly with O2- to form strong oxidant peroxynitrite (ONOO).8,33 O2- reacts 3 to 6 times faster with NO (k=9 × 109 · M-1 · s-1) to form peroxynitrite than with SOD (k=2 × 109 · M-1 · s-1) to form H2O2. Although NO concentration (order of few tens to hundreds of nanomolar34-37) in vivo is much lower than the SOD concentration (order of 10 millimolar38), once formed, ONOO- contributes to vascular dysfunction indirectly by reducing NO bioavailability and initiating a number of pathological processes. In addition to rapid reaction with O2- to form ONOO-, NO also reacts with oxygen to form nitrous anhydride (N2O3) and nitrogen dioxide (NO2). These RNS can initiate a number of pathological processes including lipid peroxidation, nitration of the protein tyrosine residues, inhibition of key metabolic enzymes, reduction of cellular antioxidant capacity by rapid oxidation of thiol, and DNA strand breaks leading to apoptosis.39,40 ONOO- also oxidizes BH4, an NOS cofactor, to dihydrobiopterin41, resulting in reduced NO formation.

II.D. Role of Mathematical Models in Oxidative and Nitrosative Stresses

Many aspects of NO, O2-, and ONOO interactions in pathophysiologic conditions such as cardiovascular disease, hypertension, and diabetes have been studied extensively in many models both in vivo and in vitro in most circumstances. The literature is full of controversies that at times arise because of reductionist approaches in methods. These controversies include (1) the role of antioxidant vitamins A, C, and E42,43 in ameliorating oxidative stress and improving disease conditions, and (2) the potential of enzyme systems such as SOD44,45 and eNOS in causing or removing oxidative and nitrosative stresses in cardiovascular systems. The causes and consequences of oxidative and nitrosative stresses depend on a delicate balance among many processes. A better understanding of NO, ROS, and RNS in biological systems will require quantitative assessment of biochemical interactions and transport of these species from a systems perspective. Mathematical modeling approaches can help to elucidate behavior of these interactions for a particular system. Though experimental studies involving the 3 important molecules (NO, O2-, and ONOO) are many, the mathematical models have been limited because of complexities of biochemical interactions. In this article, mathematical models that involve more than one of the 3 molecules (NO, O2-, and ONOO) are reviewed.

III. Kinetic Models

One of the common themes of the kinetic models is to understand how the fluxes of NO and O2- affect a particular outcome. The kinetic models of NO, O2-, and ONOO studied diverse aspects of roles of these molecules, which included (1) the kinetics of reaction of NO and superoxide,46-48 (2) superoxide dismutation catalyzed by superoxide dismutase,44,45,49,50 (3) role of GSH,46 and (4) models of O2- production from mitochondrial transport chain.

III.A. Role of Superoxide Dismutase

Three types of SODs have been identified: cytosolic CuZn-SOD,51,52 mitochondrial Mn-SOD, and extracellular SOD. All SODs catalyze the dismutation of O2- according to Reaction 1 and play an important role in modulating oxidative stress and nitrosative stress levels.

2H++202·SOD,kSODO2+H2O2kSOD=2×109·M­1·s­1 (Reaction 1)

The product of this reaction is H2O2. H2O2 is converted to O2 and H2O by enzyme catalase. SOD can play an important role in increasing NO levels by reducing.

Approximately 80% of all SOD activity can be attributed to CuZn-SOD,53-55 and its deficiency leads to impaired NO-mediated arterial relaxation. 53 Mn-SOD protects against the mitochondrial electron transport chain O2- production.33,56 Blood vessels contain smaller amounts of Mn-SOD compared with CuZn-SOD and extracellular SOD; however, endothelium may contain high levels of Mn-SOD.53,55,57 Mn-SOD differs from the other 2 isoforms in that Mn-SOD-knockout mice die less than 3 weeks after birth.58,59 Vascular smooth muscle cells produce extracellular SOD, which is found in high amounts in the interstitial space.53,55,60,61 Extracellular SOD plays an important role in the regulation of O2-.62,63

An overproduction of SOD or administration of high doses of SOD is reported to cause deleterious consequences, including cancer cell growth and ischemia reperfusion injuries, in a number of experimental studies45,64,65 The possible explanation for SOD-induced toxicity is an increased production of H2O2 in the presence of higher SOD. Most mathematical models involving SOD44,45,49,50,66,67 attempted to provide an explanation of the experimental observation of increased cell and tissue damage upon overexpression and administration of high levels of SOD (reviewed by McCord45). Results from mathematical models mostly suggested that increased levels of SOD in most cases decrease the production of H2O2.44,50,67 The decrease in the production of H2O2 is attributed to a reduction in steady state O2- concentration.

Using simple models, Gardner et al.67 and Licochev and Fridovich68 considered the effects of varying SOD from zero to normal concentrations but not pathophysiologic concentration of SOD on H2O2 production. They concluded that SOD activity affects H2O2 production only when most O2- is eliminated through H2O2 free processes. To provide an explanation for increased oxidative stress, Kowald et al.50 considered SOD to act as peroxidase and O2- reductase. In addition, they considered SOD’s role to increase lipid peroxidation by removing O2-, which serves as a terminator for lipid peroxidation. For peroxidase function, SOD reacts with H2O2 to become a free radical generator. For O2- reductase function, SOD produces one H2O2 instead of the normal 2 H2O2 for every O2- reacted, which is termed SOD cycle short circuiting. In addition, they considered the O2- radical to have alternative reaction pathways. All reactions of O2- in vivo except with SOD were lumped in these alternative pathways. They concluded that the alternative pathway mechanism and SOD as O2- reductase is the most viable explanation for SOD-associated oxidative stress.

Buettener et al.66, like others, also showed that the SOD can increase the flux of H2O2. To understand how SOD can increase the production of H2O2, they developed a kinetic model of O2--peroxide system containing 16 nonlinear differential equations from the generation of O2- radical to the final conversion of H2O2 to water inside mitochondria. The main parameters for the model were equilibrium-specific formation of superoxide (K), and SOD concentration. The equilibrium-specific formation was varied between 0.001 and 1000 by varying the reverse rate constant, and SOD concentration was varied between 0.7 and 10 μM. The model predicted that the SOD increases the steady state H2O2 level for K<1 and has no effect on H2O2 level for K>1. The K<1 and K>1 are identified as O2--producing sources of mitochondrial electron transport chain and xanthine oxidase, respectively. However, Licochev and Fridovich44 reported that the increased H2O2 formation observed by Buettner et al.66 is a result of the inclusion of dismutation reaction and not caused by an SOD-dependent increase in O2- formation.

III.B. Models of Tyrosine Nitration

Free or protein tyrosine residues nitration is a covalent posttranslational modification from nitrating agents that is observed in many disease conditions.69-72 The nitration pathways involving ONOO results in the formation of oxometal complexes and ONOOCO2 that decomposes to carbonate radical (CO3) and NO2. NO2 oxidizes tyrosine to tyrosyl radicals and reacts with tyrosyl radicals to form 3-nitrotyrosine.73 Because of the diffusion-limited reaction of NO· with O2 and the ability of ONOO reaction product to tyrosine nitration in vitro, the formation of 3-nitrotyrosine is commonly used as an indirect marker for in vivo local formation of ONOO.

The focus of the tyrosine nitration computational models has been on whether ONOO can perform as a biological nitration mediator.47,74 This question is raised because of apparent conflicting observations in nitration yield in homogenous and biological systems. Alternative pathways for tyrosine nitration also have been proposed, including transition metal-dependent mechanisms and heme-peroxidases such as myeloperoxidase and eosinophil peroxidase catalyzing free and protein tyrosine in the presence of nitrite and H2O2. In homogeneous systems, the maximal nitration yields are achieved at the NO:O2 flux ratio of approximately one,75,76 and an excess of either NO or O2 results in a decrease in nitration yields. A possible explanation for the reduced yield with an excess of NO or O2 may be deactivation of nitration with excess NO and O2 interactions with NO2 and tyrosyl radicals, respectively. However, the nitration in biological systems increases with increase in either NO or O2.77,78 This contradiction invalidates the use of 3-nitrotyrosine as a marker for ONOO.

To resolve the apparent conflict in nitration yield between the in vivo and in vitro data, Quijano et al.74 modeled the 3-nitrotyrosine formation using simultaneous fluxes of NO and O2. They hypothesized that the presence of SOD and the transmembrane diffusion of NO prevents the accumulation of NO and O2 and, therefore, the formation of ONOO. The transmembrane NO diffusion was represented with a rapid NO disappearance rate of 400 s-1. The inclusion of transmembrane NO diffusion and SOD reduces NO concentration from 12 μM to 40 pM and O2 concentration from 200 nM to 0.8 pM, respectively. Their data showed that in biological systems ONOO-mediated nitration is a low-yield process but responsive to increases in formation of NO and O2. Both the incorporation of SOD and diffusion of NO increased tyrosine nitration formation when the ratio of fluxes of NO and O2 increased beyond one. However, the nitration yields were significantly lower in the range of femtomolar per minute when both SOD and diffusion of NO were incorporated compared with nanomolar per minute range when either SOD or diffusion of NO was incorporated.

Lancaster47 systematically investigated oxidation, nitrosation, and nitration pathways to better understand the dominant reaction pathways and intermediate and product formations. The analysis indicated that oxidation, compared with nitrosation and nitration, is the dominant pathway for the fate of NO and O2. When either flux of NO or O2 varies and the other flux is constant, there is a linear increase in ONOO concentration that reaches a plateau in certain conditions. However, the ONOO concentration does not decrease with varying NO and O2 flux as required for the bellshaped curve.

It is still debatable whether ONOO is the exclusive source of tyrosine nitration in vivo. The alternative reaction mechanisms, which are normally ignored, need to be considered in tyrosine nitration in vivo, including a role for NO2·. The nitration modeling has been restricted to only tyrosine nitration. It also can be extended to nitration of tryptophan residues, DNA bases, and sugars.

IV. BIOTRANSPORT/DIFFUSION MODELS OF NITRIC OXIDE, REACTIVE OXYGEN SPECIES, AND REACTIVE NITROGEN SPECIES IN THE MICROCIRCUALTON

A common event in pathophysiologic conditions such as cardiovascular disease, hypertension, and diabetes is the reduction in bioactive NO availability, which is known as the endothelial dysfunction or impaired vasodilation.79 Many hypotheses for the cause of the endothelial dysfunction have been proposed, including lower NO formation, higher ROS formation, higher interactions among NO and ROS, alterations in cellular signaling, and the inability of endogenous antioxidant. A role of reduced availability of NOS substrates and cofactors such as oxygen, tetrahydrobiopterin, and L-arginine also has been established. Though the role of NO, O2 and ONOO interactions have been studied extensively in vivo and in vitro in normal and pathophysiologic conditions; however, the quantitative information of these interactions in the microcirculation is not available. Over last decade, I and others have developed computational and mathematical models of NO biotransport in the microcirculation (reviewed by Buerk, Barbee, and Jaron,80 in this issue). The models of NO, O2, and ONOO interactions are not many, and the important results are summarized in this section.

Chavez et al.,81 Kavdia,82 and Buerk et al.83 developed mathematical models of free radical transport in and around an arteriole. These models used detailed arteriolar vessel geometry and solved general mass transport equations for cylindrical geometry. The convective mass transport was neglected because of fast reactions of these radicals. Buerk et al.83 investigated the effect of varying O2 production rates and SOD concentrations (0.02–20 μM). The O2 formation rate was assumed to be proportional to metabolism in the different tissue layers. Chavez et al.81 and Kavdia82 investigated the role of O2 and ONOO in inactivating vasoactive NO and the O2 formation rate was assumed to be a fraction of NO production rates. Chavez et al.81 studied the effect of isoforms of SOD and Kavdia82 studied a possible role of the location of oxidative stress in vascular tissue on these interactions.

These models predicted that the highest NO level is in the endothelium. The maximum ONOO concentration occurs in the smooth muscle or in the outer vascular wall. However, the model differed in the O2 concentration predictions. Chavez et al.81 and Kavdia82 reported that the maximum O2 concentration is in endothelial cells andis significantly higher compared with O2 concentrations in any other regions of the vascular wall or lumen, whereas Buerk et al.83 reported that the O2 concentrations can be significantly high in all regions of vascular wall. The difference in O2 concentrations are because of different O2 formation rates used by these groups. The important results from these studies are that (1) the range of concentration of NO, O2, and ONOO are 50–150 nM, 0.1–300 pM, and 1–30 nM, respectively; (2) ONOO diffuses over a large distance, and (3) a reduction in SOD levels increases O2 and ONOO and decreases NO level.

These results indicate that the nitrosylation of membrane proteins and oxidization of lipids in the microcirculation may occur at diverse locations in diabetes, aging, and cardiovascular diseases. Because the location of oxidative stress vary greatly, a need for careful experiments at the individual vascular wall cell layer for oxidative stress studies in the vasculature is emphasized.82

V. INTEGRATED EXPERIMENTAL AND COMPUTATIONAL MODELS

As described above, when NO, O2, and ONOO are present in biological systems, their interaction leads to biologically significant outcomes including oxidation, nitration, and nitrosation. In biological systems, most of the methods used render nonquantitative and indirect measurements of these species. In this section, we review integrated experimental and computational models of dynamics of NO/O2/ONOO in systems including ischemia/reperfusion in rat hippocampus,48 high glucose–exposed endothelial cells in parallel plate flow chamber,84 and inactivation and nitration of SOD for varying fluxes of NO and O2.85 Note that the use of these integrated approaches leads to a quantitative understanding of complex interactions and concentrations of NO, O2, and ONOO in these diverse biological systems using different approaches.

To understand ischemia/reperfusion-related NO and ONOO concentration dynamics, Yang et al.48 measured NO concentration using a NO-selective sensor in the rat brain hippocampus during brain ischemia/reperfusion. The use of an integrated approach was to reveal ONOO dynamics. The chemical reaction network was composed of 7 reactions and 7 differential equations. The measured NO concentration and resulting NO formation rates were used to calculate the ONOO concentrations. The results indicated that during the reperfusion stage increased NO production rates can lead to a significant increase in ONOO levels.

Potdar and Kavdia84 developed an integrated experimental and computation model to provide a quantitative understanding of interaction dynamics of NO/O2/ONOO in high glucose-induced endothelial dysfunction. They measured the widely used end-products of these interactions, nitrite and nitrate, using a chemiluminescence analyzer. The developed biochemical reaction network model was used to provide estimation of NO, O2, and ONOO concentrations and productions from endothelial cells exposed to shear stress. The integrated approach revealed that both NO and O2 production of endothelial cells increased but NO bioavailability decreased upon exposure to high glucose. O2 and ONOO concentrations increased significantly upon high glucose exposure. This study emphasize the need for the recognition that there is a difference between production and level (or concentration) of these molecules and these cannot be used interchangeably, which is the case in many experimental studies. In addition, the administration of SOD decreased O2 concentration and increased NO concentration. Importantly, this study provides an explanation for the contradictory results of vitamin-E supplementation clinical studies. The study reported that NO production was inhibited and O2 production decreased upon administration of vitamin E. An inhibition of NO production and subsequent decrease in NO bioavailability might be the possible cause for worsening of endothelial function in clinical studies of vitamin E supplementation.

Demicheli et al.85 studied SOD inactivation by ONOO. The ONOO formation was achieved using simultaneous fluxes of NO and O2 with varying ratios. Exposure of 5 μM SOD to simultaneous equimolar flux of NO and O2 (10 μM/min) led to inactivation of SOD in a time-dependent manner. The SOD inactivation was partially inhibited by glutathione but not by uric acid, a scavenger for ONOO-derived radicals. They suggest that only ONOO, and not the products of hemolysis of ONOO, is responsible for inactivation of SOD. Using the integrated approach, the concentration of NO, O2, and ONOO were calculated under the experimental conditions. The NO and O2 concentrations are affected significantly by the presence of SOD. The O2 concentration changes from nanomolar to picomolar and NO concentrations changes from nanomolar to micromolar in the presence of SOD. However, ONOO concentration decreases only ~37% and is capable of reacting with multiple targets.

VI. CONCLUSIONS

Even though great advances have been made in free radical measurements, the spatial and temporal resolution of the methods have not been sufficient to measure the steep gradients, transient intermediates, and in many cases very small concentrations of free radicals. There are significant advantages of computational modeling of NO, ROS, and RNS. The modeling of these molecules complex pathways (1) can provide information about intermediate products involved in a reaction, and (2) can determine the range of parameters for a specific result and help to elucidate the precise mechanism. Because most reaction constants in the models of ROS and RNS are obtained from precise, controlled reaction medium in isolation, it is vital that integrated experimental and computational modeling approaches continue to evolve for a given biological system and account for as many pathways as required to provide a better understanding.

Acknowledgments

This study is supported by NIH grant No. R01 HL084337 and American Heart Association National SDG 0530050N.

References

  • 1.Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373–6. doi: 10.1038/288373a0. [DOI] [PubMed] [Google Scholar]
  • 2.Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A. 1987;84:9265–9. doi: 10.1073/pnas.84.24.9265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109–42. [PubMed] [Google Scholar]
  • 4.Fukumura D, Yuan F, Endo M, Jain RK. Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions. Am J Pathol. 1997;150:713–25. [PMC free article] [PubMed] [Google Scholar]
  • 5.Radomski MW, Vallance P, Whitley G, Foxwell N, Moncada S. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc Res. 1993;27:1380–1382. doi: 10.1093/cvr/27.7.1380. [DOI] [PubMed] [Google Scholar]
  • 6.Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A. 1991;88:4651–5. doi: 10.1073/pnas.88.11.4651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Marks DS, Vita JA, Folts JD, Keaney JF, Jr, Welch GN, Loscalzo J. Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J Clin Invest. 1995;96:2630–8. doi: 10.1172/JCI118328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996;271:C1424–1437. doi: 10.1152/ajpcell.1996.271.5.C1424. [DOI] [PubMed] [Google Scholar]
  • 9.Cosentino F, Luscher TF. Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol. 1998;32(Suppl 3):S54–61. [PubMed] [Google Scholar]
  • 10.Endemann DH, Schiffrin EL. Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus. Curr Hypertens Rep. 2004;6:85–9. doi: 10.1007/s11906-004-0081-x. [DOI] [PubMed] [Google Scholar]
  • 11.Forstermann U, Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation. 2006;113:1708–14. doi: 10.1161/CIRCULATIONAHA.105.602532. [DOI] [PubMed] [Google Scholar]
  • 12.Hadi HA, Carr CS, Al Suwaidi J. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag. 2005;1:183–98. [PMC free article] [PubMed] [Google Scholar]
  • 13.Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C, et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation. 2002;106:3073–8. doi: 10.1161/01.cir.0000041431.57222.af. [DOI] [PubMed] [Google Scholar]
  • 14.Lu X, Kassab GS. Nitric oxide is significantly reduced in ex vivo porcine arteries during reverse flow because of increased superoxide production. J Physiol. 2004;561:575–82. doi: 10.1113/jphysiol.2004.075218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87:315–424. doi: 10.1152/physrev.00029.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Thum T, Fraccarollo D, Schultheiss M, Froese S, Galuppo P, Widder JD, Tsikas D, Ertl G, Bauersachs J. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes. 2007;56:666–674. doi: 10.2337/db06-0699. [DOI] [PubMed] [Google Scholar]
  • 17.Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001;357:593–615. doi: 10.1042/0264-6021:3570593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Tsoukias NM. Nitric oxide bioavailability in the microcirculation: insights from mathematical models. Microcirculation. 2008;15:813–834. doi: 10.1080/10739680802010070. [DOI] [PubMed] [Google Scholar]
  • 19.Deonikar P, Kavdia M. An integrated computational and experimental model of nitric oxidered blood cell interactions. Ann Biomed Eng. 2010;38:357–70. doi: 10.1007/s10439-009-9823-x. [DOI] [PubMed] [Google Scholar]
  • 20.Deonikar P, Kavdia M. Extracellular diffusion and permeability effects on NO-RBCs interactions using an experimental and theoretical model. Microvasc Res. 2010;79:47–55. doi: 10.1016/j.mvr.2009.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Deonikar P, Kavdia M. A computational model for nitric oxide, nitrite and nitrate biotransport in the microcirculation: effect of reduced nitric oxide consumption by red blood cells and blood velocity. Microvasc Res. 2010;80:464–76. doi: 10.1016/j.mvr.2010.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Brown LA, Key BJ, Lovick TA. Fluorescent imaging of nitric oxide production in neuronal varicosities associated with intraparenchymal arterioles in rat hippocampal slices. Neurosci Lett. 2000;294:9–12. doi: 10.1016/s0304-3940(00)01521-4. [DOI] [PubMed] [Google Scholar]
  • 23.Kashiwagi S, Kajimura M, Yoshimura Y, Suematsu M. Nonendothelial source of nitric oxide in arterioles but not in venules: alternative source revealed in vivo by diaminofluorescein microfluorography. Circ Res. 2002;91:e55–64. doi: 10.1161/01.res.0000047529.26278.4d. [DOI] [PubMed] [Google Scholar]
  • 24.Vallance P, Leiper J. Blocking NO synthesis: how, where and why? Nat Rev Drug Discov. 2002;1:939–950. doi: 10.1038/nrd960. [DOI] [PubMed] [Google Scholar]
  • 25.Ichihara A, Inscho EW, Imig JD, Navar LG. Neuronal nitric oxide synthase modulates rat renal microvascular function. Am J Physiol. 1998;274:F516–24. doi: 10.1152/ajprenal.1998.274.3.F516. [DOI] [PubMed] [Google Scholar]
  • 26.Toda N, Okamura T. The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol Rev. 2003;55:271–324. doi: 10.1124/pr.55.2.3. [DOI] [PubMed] [Google Scholar]
  • 27.French S, Giulivi C, Balaban RS. Nitric oxide synthase in porcine heart mitochondria: evidence for low physiological activity. Am J Physiol Heart Circ Physiol. 2001;280:H2863–7. doi: 10.1152/ajpheart.2001.280.6.H2863. [DOI] [PubMed] [Google Scholar]
  • 28.Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86:494–501. doi: 10.1161/01.res.86.5.494. [DOI] [PubMed] [Google Scholar]
  • 29.Kojda G, Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res. 1999;43:562–71. doi: 10.1016/s0008-6363(99)00169-8. [DOI] [PubMed] [Google Scholar]
  • 30.Schulz E, Anter E, Keaney JF., Jr Oxidative stress, antioxidants, and endothelial function. Curr Med Chem. 2004;11:1093–1104. doi: 10.2174/0929867043365369. [DOI] [PubMed] [Google Scholar]
  • 31.d’Uscio LV, Milstien S, Richardson D, Smith L, Katusic ZS. Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity. Circ Res. 2003;92:88–95. doi: 10.1161/01.res.0000049166.33035.62. [DOI] [PubMed] [Google Scholar]
  • 32.Alp NJ, Channon KM. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol. 2004;24:413–20. doi: 10.1161/01.ATV.0000110785.96039.f6. [DOI] [PubMed] [Google Scholar]
  • 33.Koppenol WH, Moreno JJ, Pryor WA, Ischiropoulos H, Beckman JS. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol. 1992;5:834–42. doi: 10.1021/tx00030a017. [DOI] [PubMed] [Google Scholar]
  • 34.Bohlen HG, Nase GP. Arteriolar nitric oxide concentration is decreased during hyperglycemia-induced betaII PKC activation. Am J Physiol Heart Circ Physiol. 2001;280:H621–7. doi: 10.1152/ajpheart.2001.280.2.H621. [DOI] [PubMed] [Google Scholar]
  • 35.Kavdia M, Popel AS. Wall shear stress differentially affects NO level in arterioles for volume expanders and Hb-based O2 carriers. Microvasc Res. 2003;66:49–58. doi: 10.1016/s0026-2862(03)00008-6. [DOI] [PubMed] [Google Scholar]
  • 36.Kavdia M, Tsoukias NM, Popel AS. Model of nitric oxide diffusion in an arteriole: impact of hemoglobin-based blood substitutes. Am J Physiol Heart Circ Physiol. 2002;282:H2245–53. doi: 10.1152/ajpheart.00972.2001. [DOI] [PubMed] [Google Scholar]
  • 37.Nase GP, Tuttle J, Bohlen HG. Reduced perivascular PO2 increases nitric oxide release from endothelial cells. Am J Physiol Heart Circ Physiol. 2003;285:H507–15. doi: 10.1152/ajpheart.00759.2002. [DOI] [PubMed] [Google Scholar]
  • 38.Fridovich I. Superoxide radical: an endogenous toxicant. Annu Rev Pharmacol Toxicol. 1983;23:239–57. doi: 10.1146/annurev.pa.23.040183.001323. [DOI] [PubMed] [Google Scholar]
  • 39.Pfeiffer S, Schmidt K, Mayer B. Dityrosine formation outcompetes tyrosine nitration at low steady-state concentrations of peroxynitrite. Implications for tyrosine modification by nitric oxide/superoxide in vivo. J Biol Chem. 2000;275:6346–52. doi: 10.1074/jbc.275.9.6346. [DOI] [PubMed] [Google Scholar]
  • 40.Salgo MG, Bermudez E, Squadrito GL, Pryor WA. DNA Damage and Oxidation of Thiols Peroxynitrite Causes in Rat Thymocytes. Archives of Biochemistry and Biophysics. 1995;322:500–505. doi: 10.1006/abbi.1995.1493. [DOI] [PubMed] [Google Scholar]
  • 41.Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation. 2002;105:1656–62. doi: 10.1161/01.cir.0000012748.58444.08. [DOI] [PubMed] [Google Scholar]
  • 42.Dotan Y, Pinchuk I, Lichtenberg D, Leshno M. Decision analysis supports the paradigm that indiscriminate supplementation of vitamin E does more harm than good. Arterioscler Thromb Vasc Biol. 2009;29:1304–9. doi: 10.1161/ATVBAHA.108.178699. [DOI] [PubMed] [Google Scholar]
  • 43.Willcox BJ, Curb JD, Rodriguez BL. Antioxidants in cardiovascular health and disease: key lessons from epidemiologic studies. Am J Cardiol. 2008;101:75D–86D. doi: 10.1016/j.amjcard.2008.02.012. [DOI] [PubMed] [Google Scholar]
  • 44.Liochev SI, Fridovich I. The effects of superoxide dismutase on H2O2 formation. Free Radic Biol Med. 2007;42:1465–9. doi: 10.1016/j.freeradbiomed.2007.02.015. [DOI] [PubMed] [Google Scholar]
  • 45.McCord JM. Superoxide dismutase, lipid peroxidation, and bell-shaped dose response curves. Dose Response. 2008;6:223–8. doi: 10.2203/dose-response.08-012.McCord. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Hu TM, Hayton WL, Mallery SR. Kinetic modeling of nitric-oxide-associated reaction network. Pharm Res. 2006;23:1702–11. doi: 10.1007/s11095-006-9031-4. [DOI] [PubMed] [Google Scholar]
  • 47.Lancaster JR., Jr Nitroxidative, nitrosative, and nitrative stress: kinetic predictions of reactive nitrogen species chemistry under biological conditions. Chem Res Toxicol. 2006;19:1160–74. doi: 10.1021/tx060061w. [DOI] [PubMed] [Google Scholar]
  • 48.Yang Y, Ke-Zhou L, Ning GM, Wang ML, Zheng XX. Dynamics of nitric oxide and peroxynitrite during global brain ischemia/reperfusion in rat hippocampus: NO-sensor measurement and modeling study. Neurochem Res. 2008;33:73–80. doi: 10.1007/s11064-007-9414-x. [DOI] [PubMed] [Google Scholar]
  • 49.Kowald A, Klipp E. Alternative pathways might mediate toxicity of high concentrations of superoxide dismutase. Ann N Y Acad Sci. 2004;1019:370–4. doi: 10.1196/annals.1297.065. [DOI] [PubMed] [Google Scholar]
  • 50.Kowald A, Lehrach H, Klipp E. Alternative pathways as mechanism for the negative effects associated with overexpression of superoxide dismutase. J Theor Biol. 2006;238:828–40. doi: 10.1016/j.jtbi.2005.06.034. [DOI] [PubMed] [Google Scholar]
  • 51.Andersen PM, Nilsson P, Forsgren L, Marklund SL. CuZn-superoxide dismutase, extracellular superoxide dismutase, and glutathione peroxidase in blood from individuals homozygous for Asp90Ala CuZu-superoxide dismutase mutation. J Neurochem. 1998;70:715–20. doi: 10.1046/j.1471-4159.1998.70020715.x. [DOI] [PubMed] [Google Scholar]
  • 52.Liochev SI, Fridovich I. Copper- and zinc-containing superoxide dismutase can act as a superoxide reductase and a superoxide oxidase. J Biol Chem. 2000;275:38482–5. doi: 10.1074/jbc.M007891200. [DOI] [PubMed] [Google Scholar]
  • 53.Faraci FM, Didion SP. Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol. 2004;24:1367–73. doi: 10.1161/01.ATV.0000133604.20182.cf. [DOI] [PubMed] [Google Scholar]
  • 54.Fridovich I. Superoxide anion radical (O2-.), superoxide dismutases, and related matters. J Biol Chem. 1997;272:18515–7. doi: 10.1074/jbc.272.30.18515. [DOI] [PubMed] [Google Scholar]
  • 55.Stralin P, Karlsson K, Johansson BO, Marklund SL. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol. 1995;15:2032–2036. doi: 10.1161/01.atv.15.11.2032. [DOI] [PubMed] [Google Scholar]
  • 56.Hsu JL, Hsieh Y, Tu C, O’Connor D, Nick HS, Silverman DN. Catalytic properties of human manganese superoxide dismutase. J Biol Chem. 1996;271:17687–91. doi: 10.1074/jbc.271.30.17687. [DOI] [PubMed] [Google Scholar]
  • 57.Suzuki K, Tatsumi H, Satoh S, Senda T, Nakata T, Fujii J, Taniguchi N. Manganese-superoxide dismutase in endothelial cells: localization and mechanism of induction. Am J Physiol. 1993;265:H1173–1178. doi: 10.1152/ajpheart.1993.265.4.H1173. [DOI] [PubMed] [Google Scholar]
  • 58.Lebovitz RM, Zhang H, Vogel H, Cartwright J, Jr, Dionne L, Lu N, et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci U S A. 1996;93:9782–7. doi: 10.1073/pnas.93.18.9782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Loch T, Vakhrusheva O, Piotrowska I, Ziolkowski W, Ebelt H, Braun T, et al. Different extent of cardiac malfunction and resistance to oxidative stress in heterozygous and homozygous manganese-dependent superoxide dismutase-mutant mice. Cardiovasc Res. 2009;82:448–57. doi: 10.1093/cvr/cvp092. [DOI] [PubMed] [Google Scholar]
  • 60.Fattman CL, Schaefer LM, Oury TD. Extracellular superoxide dismutase in biology and medicine. Free Radic Biol Med. 2003;35:236–56. doi: 10.1016/s0891-5849(03)00275-2. [DOI] [PubMed] [Google Scholar]
  • 61.Marklund SL. Extracellular superoxide dismutase. Methods Enzymol. 2002;349:74–80. doi: 10.1016/s0076-6879(02)49322-6. [DOI] [PubMed] [Google Scholar]
  • 62.Sjoquist PO, Marklund SL. Endothelium bound extracellular superoxide dismutase type C reduces damage in reperfused ischaemic rat hearts. Cardiovasc Res. 1992;26:347–350. doi: 10.1093/cvr/26.4.347. [DOI] [PubMed] [Google Scholar]
  • 63.Stralin P, Marklund SL. Effects of oxidative stress on expression of extracellular superoxide dismutase, CuZn-superoxide dismutase and Mn-superoxide dismutase in human dermal fibroblasts. Biochem J. 1994;298(Pt 2):347–352. doi: 10.1042/bj2980347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Dasgupta J, Subbaram S, Connor KM, Rodriguez AM, Tirosh O, Beckman JS, et al. Manganese superoxide dismutase protects from TNF-alpha-induced apoptosis by increasing the steady-state production of H2O2. Antioxid Redox Signal. 2006;8:1295–305. doi: 10.1089/ars.2006.8.1295. [DOI] [PubMed] [Google Scholar]
  • 65.Venkataraman S, Jiang X, Weydert C, Zhang Y, Zhang HJ, Goswami PC, Ritchie JM, Oberley LW, Buettner GR. Manganese superoxide dismutase overexpression inhibits the growth of androgen-independent prostate cancer cells. Oncogene. 2005;24:77–89. doi: 10.1038/sj.onc.1208145. [DOI] [PubMed] [Google Scholar]
  • 66.Buettner GR, Ng CF, Wang M, Rodgers VG, Schafer FQ. A new paradigm: manganese superoxide dismutase influences the production of H2O2 in cells and thereby their biological state. Free Radic Biol Med. 2006;41:1338–50. doi: 10.1016/j.freeradbiomed.2006.07.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Gardner R, Salvador A, Moradas-Ferreira P. Why does SOD overexpression sometimes enhance, sometimes decrease, hydrogen peroxide production? A minimalist explanation. Free Radic Biol Med. 2002;32:1351–7. doi: 10.1016/s0891-5849(02)00861-4. [DOI] [PubMed] [Google Scholar]
  • 68.Liochev SI, Fridovich I. Superoxide and nitric oxide: consequences of varying rates of production and consumption: a theoretical treatment. Free Radic Biol Med. 2002;33:137–41. doi: 10.1016/s0891-5849(02)00864-x. [DOI] [PubMed] [Google Scholar]
  • 69.Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys. 1998;356:1–11. doi: 10.1006/abbi.1998.0755. [DOI] [PubMed] [Google Scholar]
  • 70.MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci U S A. 1996;93:11853–8. doi: 10.1073/pnas.93.21.11853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Peluffo G, Radi R. Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc Res. 2007;75:291–302. doi: 10.1016/j.cardiores.2007.04.024. [DOI] [PubMed] [Google Scholar]
  • 72.Turko IV, Murad F. Protein nitration in cardiovascular diseases. Pharmacol Rev. 2002;54:619–34. doi: 10.1124/pr.54.4.619. [DOI] [PubMed] [Google Scholar]
  • 73.Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci U S A. 2004;101:4003–8. doi: 10.1073/pnas.0307446101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Quijano C, Romero N, Radi R. Tyrosine nitration by superoxide and nitric oxide fluxes in biological systems: modeling the impact of superoxide dismutase and nitric oxide diffusion. Free Radic Biol Med. 2005;39:728–41. doi: 10.1016/j.freeradbiomed.2005.04.014. [DOI] [PubMed] [Google Scholar]
  • 75.Hodges GR, Marwaha J, Paul T, Ingold KU. A novel procedure for generating both nitric oxide and superoxide in situ from chemical sources at any chosen mole ratio. First application: tyrosine oxidation and a comparison with preformed peroxynitrite. Chem Res Toxicol. 2000;13:1287–93. doi: 10.1021/tx0001272. [DOI] [PubMed] [Google Scholar]
  • 76.Sawa T, Akaike T, Maeda H. Tyrosine nitration by peroxynitrite formed from nitric oxide and superoxide generated by xanthine oxidase. J Biol Chem. 2000;275:32467–32474. doi: 10.1074/jbc.M910169199. [DOI] [PubMed] [Google Scholar]
  • 77.Boczkowski J, Lisdero CL, Lanone S, Samb A, Carreras MC, Boveris A, et al. Endogenous peroxynitrite mediates mitochondrial dysfunction in rat diaphragm during endotoxemia. FASEB J. 1999;13:1637–46. doi: 10.1096/fasebj.13.12.1637. [DOI] [PubMed] [Google Scholar]
  • 78.Eliasson MJ, Huang Z, Ferrante RJ, Sasamata M, Molliver ME, Snyder SH, et al. Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. J Neurosci. 1999;19:5910–8. doi: 10.1523/JNEUROSCI.19-14-05910.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87:840–4. doi: 10.1161/01.res.87.10.840. [DOI] [PubMed] [Google Scholar]
  • 80.Buerk DG, Barbee KA, Jaron D. Nitric oxide signaling in the microcirculation. Biomed Eng. 2011 doi: 10.1615/critrevbiomedeng.v39.i5.40. in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Chavez MD, Lakshmanan N, Kavdia M. Impact of superoxide dismutase on nitric oxide and peroxynitrite levels in the microcirculation--a computational model. Conf Proc IEEE Eng Med Biol Soc. 2007;2007:1022–6. doi: 10.1109/IEMBS.2007.4352468. [DOI] [PubMed] [Google Scholar]
  • 82.Kavdia M. A computational model for free radicals transport in the microcirculation. Antioxid Redox Signal. 2006;8:1103–11. doi: 10.1089/ars.2006.8.1103. [DOI] [PubMed] [Google Scholar]
  • 83.Buerk DG, Lamkin-Kennard K, Jaron D. Modeling the influence of superoxide dismutase on superoxide and nitric oxide interactions, including reversible inhibition of oxygen consumption. Free Radic Biol Med. 2003;34:1488–503. doi: 10.1016/s0891-5849(03)00178-3. [DOI] [PubMed] [Google Scholar]
  • 84.Potdar S, Kavdia M. NO/peroxynitrite dynamics of high glucose-exposed HUVECs: chemiluminescent measurement and computational model. Microvasc Res. 2009;78:191–8. doi: 10.1016/j.mvr.2009.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Demicheli V, Quijano C, Alvarez B, Radi R. Inactivation and nitration of human superoxide dismutase (SOD) by fluxes of nitric oxide and superoxide. Free Radic Biol Med. 2007;42:1359–68. doi: 10.1016/j.freeradbiomed.2007.01.034. [DOI] [PubMed] [Google Scholar]
  • 86.Wink DA, Hines HB, Cheng RY, Switzer CH, Flores-Santana W, Vitek MP, Ridnour LA, Colton CA. Nitric oxide and redox mechanisms in the immune response. J Leukoc Biol. 2011 doi: 10.1189/jlb.1010550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Nediani C, Raimondi L, Borchi E, Cerbai E. Nitric oxide/reactive oxygen species generation and nitroso/redox imbalance in heart failure: from molecular mechanisms to therapeutic implications. Antioxid Redox Signal. 2011;14:289–331. doi: 10.1089/ars.2010.3198. [DOI] [PubMed] [Google Scholar]
  • 88.Metodiewa D, Koska C. Reactive oxygen species and reactive nitrogen species: relevance to cyto(neuro)toxic events and neurologic disorders. An overview. Neurotox Res. 2000;1:197–233. doi: 10.1007/BF03033290. [DOI] [PubMed] [Google Scholar]
  • 89.Boueiz A, Hassoun PM. Regulation of endothelial barrier function by reactive oxygen and nitrogen species. Microvasc Res. 2009;77:26–34. doi: 10.1016/j.mvr.2008.10.005. [DOI] [PubMed] [Google Scholar]
  • 90.Powers SK, Talbert EE, Adhihetty PJ. Reactive oxygen and nitrogen species as intracellular signals in skeletal muscle. J Physiol. 2011;589(Pt 9):2129–38. doi: 10.1113/jphysiol.2010.201327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Fialkow L, Wang Y, Downey GP. Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic Biol Med. 2007;42:153–64. doi: 10.1016/j.freeradbiomed.2006.09.030. [DOI] [PubMed] [Google Scholar]
  • 92.Duan J, Kasper DL. Oxidative depolymerization of polysaccharides by reactive oxygen/nitrogen species. Glycobiology. 2010;21:401–9. doi: 10.1093/glycob/cwq171. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES